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Background and purpose: Stereotactic lung radiotherapy (SLRT) has emerged as a curative treatment for medically
inoperable patients with early-stage non-small cell lung cancer (NSCLC) and the use of intensity-modulated
radiotherapy (IMRT) and volumetric modulated arc treatments (VMAT) have been proposed as the best practical
approaches for the delivery of SLRT. However, a large number of narrow field shapes are needed in the dose delivery
of intensity-modulated techniques and the probability of underdosing the tumour periphery increases as the effective
field size is decreased. The purpose of this study was to evaluate small lung tumour doses irradiated by intensity-
modulated techniques to understand the risk for dose calculation errors in precision radiotherapy such as SLRT.
Materials and methods: The study was executed with two heterogeneous phantoms with targets of 1.5 and
4.0 cm. Dose distributions in the simulated tumours delivered by small sliding window apertures (SWAs), IMRT and
RapidArc treatment plans were measured with radiochromic film. Calculation algorithms of pencil beam convolution
(PBC) and anisotropic analytic algorithm (AAA) were used to calculate the corresponding dose distributions.
Results: Peripheral doses of the tumours were decreased as SWA decreased, which was not modelled by the calculation
algorithms. The smallest SWA studied was 2 mm, which reduced the 90% isodose line width by 4.2 mm with the
4.0 cm tumour as compared to open field irradiation. PBC was not able to predict the dose accurately as the gamma
evaluation failed to meet the criteria of ±3%/±1 mm on average in 61% of the defined volume with the smaller tumour.
With AAA the corresponding value was 16%. The dosimetric inaccuracy of AAA was within ±3% with the optimized
treatment plans of IMRT and RapidArc. The exception was the clinical RapidArc plan with dose overestimation of 4%.
Conclusions: Overall, the peripheral doses of the simulated lung tumours were decreased by decreasing the SWA. To
achieve adequate surface dose coverage to small lung tumours with a difference less than 1 mm in the isodose line
radius between the open and modulated field, a larger than 6 mm SWA should be used in the dose delivery of SLRT.
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Stereotactic lung radiotherapy (SLRT) is an effective
treatment option for malignant pulmonary tumours
that measure 6 cm or less [1,2]. In SLRT a high dose of
radiation is given with few treatment fractions and a high
probability of tumour control can be achieved when
compared to the conventional fractionation [3,4]. Clinical
outcomes of SLRT for peripheral primary lung tumours* Correspondence: jan.seppala@kuh.fi
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reproduction in any medium, provided the orare comparable to surgery and this is one of the reasons
that SLRT is rapidly increasing in the treatment of small
lung tumours [5,6]. The use of intensity-modulated
radiotherapy (IMRT) and volumetric modulated arc
treatments (VMAT) has been evaluated and proposed
over 3D-CRT techniques for the delivery of SLRT [7-9].
However, with the increased complexity in beam shap-
ing a large number of narrow field shapes are needed
in the dose delivery. This situation becomes a clinical
concern when the irradiated volume is located in lung
tissue, where the secondary Compton electrons have a
wider range. Dose rebuild-up and rebuild-down effectsl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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steeper when the field size is decreased [10]. As a result
underdosing effects take place at the lung-tumour inter-
face potentially decreasing the minimum dose delivered
to the tumour, which in turn can decrease the tumour
control probability [11].
The inadequacy of the most common, type-a algo-
rithms, such as pencil beam convolution (PBC) to calcu-
late the dose accurately inside heterogeneous media is
well documented [12,13]. The type-b calculation algo-
rithms, such as collapsed cone (CC) and anisotropic ana-
lytic algorithms (AAA) are able to approximate the
electron transport in heterogeneous media more accur-
ately than the PBC algorithm [14-16]. The dosimetric
accuracy of these algorithms is, however, controversial
and depends on field size, beam energy and density of
lung investigated. Monte Carlo simulation is assumed to
be the best representation of the real dose distribution.
Recently new Monte Carlo codes have been developed,
which allow the simulations of complex IMRT and
VMAT delivery techniques [17]. Unfortunately, full
Monte Carlo have not gained widespread clinical use yet
since the simulations with high spatial resolution are
laborious and time-consuming.
The accuracy of different dose calculation algorithms
has been studied in the treatments of SLRT mainly with
the conventional 3D-techniques with relatively large field
sizes as compared to the effective field sizes used in inten-
sity modulated techniques [12,18,19]. Numerous studies
have also compared the calculated doses of type-a and
type-b algorithms but unfortunately the measurements
with IMRT dose delivery methods have been sparse
[20,21]. To our knowledge, dose accuracy of IMRT or
RapidArc, a form of VMAT, in a heterogeneous phantom
has been performed only once [22]. However, studies to
investigate the effect of small MLC apertures of the IMRTFigure 1 Measurement set-up. The outer PMMA cylinder was attached to
inside. A frontal view of the 4.0 cm tumour surrounded by cork with filmor RapidArc to the surface doses of small tumours have
not been conducted. The aim of this work was to evaluate
the dosimetric accuracy of IMRT and RapidArc techni-
ques in SLRT using heterogeneous phantoms. Another
purpose of this study was to define the smallest sliding
window aperture (SWA) that can be used in SLRT with-
out compromising the peripheral doses of the treated lung
tumours.
Methods and materials
The effect of lung heterogeneities on tumour central and
peripheral doses was studied with a Novalis Tx linear ac-
celerator (Varian Medical Systems, Palo Alto, CA and
BrainLAB, München, Germany) with a photon energy of 6
MV. Higher energies were neglected since the dosimetric
advantages of lower photon energies have been well docu-
mented in SLRT [15,23]. The Novalis Tx is equipped with
a high-definition multileaf collimator (HD-MLC) with a
total of 60 leaf pairs with central leaves of width 2.5 mm
and the peripheral leaves 5 mm in the isocentre.
Phantoms
Two heterogeneous phantoms, made of polymethyl
methacrylate (PMMA, ρ= 1.18 g/cm3), polycarbonate
and cork, were designed for this study (Figure 1). Spher-
ical polycarbonate inserts of 1.5 cm and 4.0 cm mim-
icked the lung tumours with an average density of 50
HU. Tumours were surrounded by cylindrical cork
(average density of −550 HU) with a diameter of 14 cm.
The phantoms were cut in half so that an EBT2 film
(Gafchromic; ISP, Wayne, NJ) could be placed in the
middle of the tumour (Figure 1B). The cylinders were
designed so that they were reproducibly insertable to a
cylindrical outer ring mimicking thoracic wall with a
thickness of 3 cm constructed from PMMA. In addition
to be able to accurately repeat the film positioning in thea stereotactic frame (A) and the cork cylinders (B) were inserted
inside (C).
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with fixed distances (Figure 1C). The films had the cor-
responding holes to fit these pins.
Two additional phantoms made of solid PMMA were
constructed to execute measurements in homogeneous
media with two ionization chambers (Farmer NE 2571
and PTW Micro chamber). The solid PMMA inserts
had tailored cavities in the middle of the phantom to fit
the chambers inside.
Treatment planning
The phantoms were imaged with a 16-slice CT scanner
(GE LightSpeed; General Electric Medical Systems, Mil-
waukee, WI) with a slice thickness of 1 mm. The CT-
images were transferred to the treatment planning sys-
tem (EclipseTM, version 8.909, Varian Medical Systems).
Tumours were contoured to the 3D-images of the phan-
toms and a margin of 5 mm was added to the tumour
resulting in a planning target volume (PTV).
The rebuild-up effects in the tumours were studied
with SWAs of 2, 4, 6, 10 and 15 mm created in Shaper
software (Varian Medical Systems). The sliding apertures
had a constant velocity with a constant dose rate of 500
MU/min. First only one anterior field was used to calcu-
late the doses from open fields and from the created
SWAs to the phantoms. The isocentres of the treatment
plans were set 1 cm off axis from the centre of the
tumours to reduce the attenuation effect of the film it-
self [24]. The secondary collimators had fixed asymmet-
ric field sizes of 2.5 × 2.5 cm2 and 5 × 5 cm2 with the
small and the large tumour, respectively. The movement
of the known apertures started from outside the second-
ary collimators. In addition ‘clinical’ nine field treatment
plans with equally spaced gantry angles were created to
study the dose distributions in the tumours. A total of
nine treatment plans with each tumour insert were studied:
five treatment plans with the various SWAs, a plan with
open fields of 2.5 × 2.5 cm2 or 5× 5 cm2 (3D-CRT plan), an
IMRT treatment plan with dynamic delivery and two Rapi-
dArc plans. IMRT treatment plan optimization focused
only on the tumour dose coverage and homogeneity. The
minimum dose to the tumour volume was set to be greater
than 0.985 Gy and the maximum dose less than 1.015 Gy.
With the first RapidArc plan (RA1) dose optimization con-
straints were only used for tumour dose coverage and uni-
formity with minimum dose objective to tumour volume
0.99 Gy and maximum dose objective less than 1.015 Gy
with one fraction. The second RapidArc plan (RA2)
optimization included also organs at risks specified in
the phantom volume. The delineated volumes simulated
heart and spinal cord with maximum dose limits of
0.2 Gy and 0.3 Gy, respectively. The arc rotations were
360o with a collimator rotation of 45o with both RA1
and RA2.The dose distributions were calculated with PBC with
modified Batho power law and with AAA (version 8.908)
with the smallest calculation grid sizes available (1.25 mm
and 1.0 mm, respectively). A prescription dose of 1 Gy
was chosen since the clinical doses of 12-20 Gy were out
of the range of the EBT2 films.
Dose delivery
The outer PMMA-cylinder was fixed to the treatment table
with a stereotactic head ring (BrainLAB AB) (Figure 1A).
Cork cylinders were inserted into the outer cylinder either
parallel or perpendicular to vertical axis and the isocentres
were localized with CBCT and ExacTrac 6D. Films were
irradiated both perpendicular and parallel to the central
beam axis. Ionization chamber measurements were per-
formed only with the fixed anterior beam in a homoge-
neous cylinder with the various SWAs and open fields,
respectively.
Film dosimetry
Two holes were cut to the films with fixed distances
from each other to match the pins in the phantoms. The
film measurements were repeated three times and aver-
aged together to reduce the variability of an individual film.
From each sheet of the film two additional pieces
(5 × 5 cm2) were irradiated to a dose of 1 Gy and two
were set as reference films of 0 Gy. The 1 Gy reference
films were used to rescale the measurements to account
for the possible variation in the sensitivity of each sheet
of a film. The films were scanned at RGB-mode at 72
dpi with no corrections in the scanner always at the
same position at the centre of the scanning bed of Epson
V700 scanner (Seiko Epson Corporation, Nagano, Japan)
24 h after the irradiation [25]. Scanner output variations
were recorded by a fixed reference film located above
the irradiated films.
Scanned films were analyzed with OmniPro I’mRT
software (version 1.7, IBA Dosimetry, Schwarzenbruck,
Germany). Within the software the films were aligned
with respect the two fixed holes in the film and were
centred to the middle of the upper hole. Responses of
the films to irradiation were measured in the red colour
channel and the optical densities were converted to dose
according to the calibration films. The standard deviation
(SD) of three independent measurements of the central
doses of the tumours was used to quantify the uncertainty
of the measured dose. The peripheral doses of the tumours
were analyzed by measuring the X- and Y-coordinate
widths of 50%, 80%, 85%, 90% and 95% isodose lines.
Results
The ionization chamber dose measurements were com-
pared to the calculations and the results are shown in
Table 1. The largest deviations (maximum 6.6%) were
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The difference between AAA and PBC in the homoge-
neous phantom was small. The film measurements were
performed in heterogeneous phantom both parallel and
perpendicular to the beam axis and the results from the
direct anterior beam measurements are shown in Table 1.
PBC overestimated the central doses of the tumours
irradiated by open fields with a maximum dose differ-
ence of 6.0%. As a consequence the calculated doses of
the small SWAs were closer to the measured values with
PBC than with the AAA since the calculated doses of
the small SWAs were on the contrary underestimated.
The measurement error was approximated by a SD of
the three discrete film measurements with an average
SD of 1.6% (range 0.3% - 3.7%). The variation in the
scanner output was recorded from the reference film
and was at maximum 0.6% (average <0.1%).
Dose in the centre of the simulated lung tumours
was measured with various treatment plans. The ac-
tual doses delivered by the calculated monitor units
(MU) by PBC and AAA are shown in Figure 2. The
results were congruent with the single anterior field
measurements as the differences between calculated
and measured doses were greater with the smaller
than with the larger tumour. Measurements of the
RapidArc treatment plans deviated on average 2.7%
(SD 1.9%) from the 3D-CRT plans, while with IMRT
treatment plans the difference was on average 0.6%
(SD 1.1%). With RA2 treatment plan the difference
between planned and measured dose distribution was
increased, as can be seen in Figure 3.Table 1 Dose differences (Measured – Calculated) in the centr
field irradiations and the standard deviations (SD) of the thre
Chamber measurements Film measurem
Homogeneous Phantom Heterogeneou
Measured - AAA Measured - PBC Measured - AA
(cGy) (cGy) (cGy)
1.5 cm 10 × 10 cm2 −1,3 −0,8 −0,9
2.5 × 2.5 cm2 −0,5 0,7 −0,7
SWA 2 mm 5,7 6,6 5,8
SWA 4 mm 3,4 4,4 5,1
SWA 6 mm 2,0 3,0 2,8
SWA 10 mm 1,9 2,9 3,4
SWA 15 mm 1,4 2,4 1,5
4.0 cm 10 × 10 cm2 −1,3 −0,8 −0,7
5.0 × 5.0 cm2 −0,7 0,2 −0,1
SWA 2 mm 1,4 2,4 1,5
SWA 4 mm 0,8 1,9 2,1
SWA 6 mm 0,8 1,9 1,5
SWA 10 mm 0,3 1,4 1,2
SWA 15 mm 0,5 1,6 1,1Isodose line widths of 50%, 80%, 85%, 90% and 95%
were studied to quantify the difference in surface doses
from various SWAs. The film measurements from the
open field irradiations (3D-CRT) were set as a reference
width. With this we wanted to quantify the impact of
the modulated fields to the surface doses of the tumours.
The dose in tumour periphery was decreased as the
SWA decreased, which is visible in Figure 4. With focus
on the treatment plans the difference in isodose line
width in the X- and Y-direction as a function of SWA is
shown in Figure 5 (SWA – 3D-CRT). The X- and Y-
directions denote the MLC leaf movement and cranio-
caudal directions, respectively. The largest difference
was recorded in the X-direction with the 4.0 cm
tumour: the 90% isodose line was 4.2 mm narrower with
2 mm SWA than with the 3D-CRT treatment plan (Fig-
ure 5). The deviation in the Y-direction with all SWAs
and tumour sizes was less than 1 mm. The dynamic
IMRT dose distributions of the AAA and the PBC are
calculated from the fluence distribution created from ac-
tual leaf positions. As a result the dose distributions cal-
culated with AAA (and PBC) with all the SWAs had the
same tumour surface doses as the corresponding open
field irradiation regardless of the sliding window aper-
ture size since they all generate an uniform radiation
distribution.
As the differences between calculated and measured dose
distributions were investigated, the PBC overestimated the
peripheral doses, which is evident in Figure 6D. The
largest difference was 8.1 mm with an isodose line of 95%
while the average difference was 3.8 mm (SD 1.7 mm) withe of 1.5 cm and 4.0 cm tumours of the single anterior
e discrete film measurements
ents, single field irradiations
s Phantom, Perpendicular Heterogeneous Phantom, Parallel
A Measured - PBC SD Measured - AAA Measured - PBC SD
(cGy) (cGy) (cGy) (cGy) (cGy)
−5,1 1,5 −1,8 −6,4 0,9
−6,0 1,8 0,3 −3,9 1,8
−0,3 3,7 3,1 −1,6 1,8
−0,9 2,0 3,9 −0,8 2,7
−3,1 2,1 3,6 −1,0 2,5
−2,5 1,1 3,1 −1,6 1,8
−4,2 0,5 2,7 −1,9 2,0
−4,6 0,3 −0,6 −4,4 1,4
−0,4 0,7 2,3 2,3 0,6
1,7 1,4 −1,6 −1,1 0,9
2,3 1,9 2,0 2,5 2,6
1,6 1,0 0,6 1,1 1,7
1,3 1,7 4,2 4,7 1,8
1,3 1,7 4,0 4,5 1,1
Figure 2 Measured central doses of the tumours (1.5 cm and 4.0 cm) with the calculated MUs of PBC and AAA. The dose prescription
was 1.0 Gy to the centre of the mimicked tumour. The error bars represent the 95% confidence intervals of the measurements.
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more accurately than the X-direction with an average dif-
ference of 2.5 mm (SD 1.4 mm) and 5.0 mm (SD 1.1 mm),
respectively. AAA, on the contrary, underestimated the
peripheral doses of the tumours with an average error of
1.1 mm (SD 0.6 mm) with the isodose lines of 80-Figure 3 Film measurements of the RA1 (A) and RA2 (D) treatment pl
AAA calculations (B and E) and the related absolute differences (C and F) (c
dashed line.95%. Agreement of the isodose lines was better in the
X-direction (0.5 mm, SD 0.5 mm) than in the Y-direction
(1.5 mm, SD 0.2 mm). The difference between the mea-
sured and calculated (PBC and AAA) isodose line widths
of 50% was on average 0.3 mm (SD 0.7 mm). The overall
accuracy of PBC and AAA was evaluated with gammaans of the 4.0 cm tumour. The corresponding dose distributions of
alculated - measured). The border of the tumour is visualized with a
Figure 4 Measured dose distributions of 2 mm (A) and 15 mm (B) SWAs were subtracted from the corresponding open field
measurement of 2.5 × 2.5 cm2 (C and D). Films were perpendicular to the beam axis in the middle of the 1.5 cm tumour.
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area of the defined region of interest (ROI: 5 × 5 cm2 and
2.5 × 2.5 cm2 with large and small tumour sizes, respect-
ively) which failed the criteria of ±3%/±1 mm were on
average 47% and 61% with PBC with large and small
tumour, respectively. The corresponding average values
for the AAA were 13% and 16%, respectively.
Discussion
The use of IMRT and VMAT techniques is increasing in
SLRT and thus the effective field sizes are smaller com-
pared to conventional 3D-CRT. Data evaluating the
dosimetric accuracy of modulated techniques applied in
SLRT is sparse and possible underdosage of the central
or peripheral parts of the tumour may compromise opti-
mal tumour control [26]. The purpose of this study was
to evaluate the actual doses of small lung tumours irra-
diated by intensity-modulated techniques to understand
the risk for dose calculation errors in precision RT such
as SLRT. The experimental set-up used in this study was
chosen such way that the impact of aperture size on the
surface doses of simulated tumours could be quantified.
Although our findings are not directly comparable to
previous studies it is relevant to relate them to existing
data. Sikora et al. [18] studied stereotactic lung IMRT
dose distributions with radiographic film measurements,Monte Carlo simulations and PBC calculations with
tumour sizes of 2.7, 4.2 and 5.0 cm in diameter. The
measurements, however, were performed only for a con-
formal plan consisting of one vertical beam. The central
doses were underestimated by PBC approximately by 5%
and 6% with 6 MV with tumour sizes of 2.7 cm and
4.2 cm, respectively. In our study, on the contrary, PBC
algorithm overestimated the central dose on average 5%
for the smaller tumour studied and underestimated the
central dose by 1% with the larger tumour. Dobler et al.
[12] used a conventional treatment plan to irradiate a
tumour insert of 2 cm diameter and 4 cm height with 6
MV photons. In their report PBC overestimated the dose
up to 5.4% while CC algorithm underestimated the dose
by 5.0%. In our study the difference between measured
and AAA calculated dose with the 3D-CRT-treatment
plan was less than 2%. In a study of Panettieri et al. [19]
spherical tumours of 2 cm and 5 cm in diameter were
studied with conventional treatment fields. Central doses
of the tumours were calculated accurately with PBC and
CC algorithms but in the target periphery the doses were
overestimated up to 10%. In general, PBC tends to over-
estimate the target dose of small tumours surrounded by
lung [27], which is apparent in the smaller tumour of
our study (Figure 2). However, with the studied larger
tumour (4 cm) PBC algorithm calculated the dose in
Figure 5 Difference in measured surface doses represented by the difference in isodose line widths of the treatment plans of 3D-CRT
and various SWAs (SWA - 3D-CRT). The mimicked lung tumours of 1.5 cm and 4.0 cm were irradiated with the nine field treatment plans.
The widths of normalized isodose lines (50%, 80%, 85%, 90% and 95%) were measured from the irradiated films to X- and Y-direction.
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peripheral doses were overestimated.
AAA is a more advanced calculation algorithm than the
PBC algorithm. Although, there are also limitations in the
accuracy of AAA as the divergent scatter of heterogeneities
from upper levels is not correctly taken into account
and the use of a discrete number of angular sectors
might cause smoothening out of the calculated dose
distribution near heterogeneous interfaces [28]. With
the studied heterogeneous phantoms AAA was able to
predict the tumour dose accurately. The difference between
the calculated and the measured doses was generally in the
range of ±3% except for the very small SWAs and the small
tumour, where the difference tended to increase as a func-
tion of decreasing SWA (see Figure 2). The main reason
for this discrepancy is probably due to the rounded leaf
end transmission (dosimetric leaf separation, DLS) and leaf
transmission values, which were optimized for conven-
tional treatment plans and for the junction areas of dynam-
ically split IMRT fields. The beam hardening effect
becomes also more pronounced by decreasing the SWA
because more radiation is penetrating the MLC. Beam
hardening effect cannot be modelled in the Eclipse beam
configuration since it uses a constant-value model. The
values of DLS and leaf transmission used in this study were0.6 mm and 2.0%, respectively. Chang et al. [29] measured
the DLS of the HD-MLC to be 0.84 mm for the energy of
6 MV with leaf leakage of 1.0%. From Figure 2 it is evident
that very small target volumes are sensitive to the dosimet-
ric settings of the HD-MLC. When the target volume gets
larger (in this study 4.0 cm) the calculation errors
decreases, although the percentage of dose coming from
leaf transmission increases. Future studies of the discrepan-
cies between the calculated and measured dose are required
to minimize the dose calculation errors in small targets.
The typical values of individual leaf separations with
dynamic IMRT treatments are usually between 5 and
15 mm depending on the beam modulation. The average
leaf openings with the IMRT treatment plans studied
were 12 and 15 mm for the small and large tumour, re-
spectively. With the RA1 treatment plans the corre-
sponding values were 7.9 and 23.7 mm and with the
RA2 plans the related values were 7.0 and 13.6 mm. The
PBC algorithm underestimated the dose in the centre of
the 4.0 cm target with the studied IMRT treatment
plan by 4% (Figure 2). The main reason for this is that
the leaf transmission and DLS values were optimized for
the treatment plans calculated with AAA. The optimal
values for the PBC calculated treatment plans would be
different since the PBC models only the primary photon
Figure 6 Measured dose distribution of the IMRT treatment plan of 4.0 cm tumour (A) was subtracted from the calculated dose
distributions of PBC (B) and AAA (C) (D and E), respectively. The border line of the tumour is visualized with a dashed line.
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the accelerator head.
The largest deviation of the central doses of the
tumours with the IMRT and RapidArc treatment plans
was observed with the RA2 treatment plan of the small
tumour. AAA underestimated the central dose by 4%,
while in the larger tumour the dose was overestimated
by 1% (Figure 2). Fog et al. [30] observed the same effect
in homogeneous phantom with a small target (0.4 cm3).
In their study the measured doses delivered by RapidArc
and HD-MLC were 20% greater than the calculated ones
for the small PTV while for the larger PTV there was
good agreement between calculated data and measure-
ments. In our study, we also noticed that with greater
beam intensity modulation (RA2) the measured dose
distribution was less homogenous than the calculated
one, which is visible in Figure 3.The quantity of dose build-up in the vicinity of lung
equivalent heterogeneities is proportional to the width of
the MLC leaf pairs: the smaller the aperture, the bigger
the build-up region at the lung-tumour interface. Indeed,
we observed a more than a 2 mm decrease in isodose
line width with SWAs of 2 mm and 4 mm to the direc-
tion of leaf travel and beam direction (Figure 5). The de-
crease in tumour peripheral doses was not modelled by
the AAA or the PBC. The maximum difference of
4.2 mm in isodose line diameter with the nine field
treatment plans was recorded with a SWA of 2 mm and
with the 4.0 cm tumour, respectively. The highest
deviations were recorded with the 85% and 90% isodose
lines as can be seen in Figure 5. When the difference
was converted to dose difference, the deviation in dose
was on average 6%. Surprisingly the difference in isodose
line width was smaller with the 1.5 cm tumour, which
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larger than 6 mm the maximum difference between iso-
dose line radius of open and modulated treatment plan
was decreased down to 1 mm. The main reason for the
surface dose difference between the open and modulated
fields is probably due to the increased rebuild-up and re-
build-down effects at the mimicked tumour and lung
interfaces with the small apertures.
The dosimetric inaccuracy of a single EBT2 film meas-
urement has been reported to be 3.8% in the dose range
of 0–4 Gy [25]. We repeated the measurements three
times to increase the overall accuracy of the used EBT2
dosimeter. The individual film measurements were pre-
sumed to be normally distributed and the SD of the film
measurements was used to estimate the measurement
inaccuracy, which was on average 1.6%.
Our study is impeded by few limitations. We neglected
the movement of the tumour caused by breathing and
the setup of the study is thus best comparable to treating
patients with active breath hold techniques or having
tumours with a very limited movement. Alternatively
respiration-correlated 4D-CT can be used to visualize
tumour motion and treatment plan optimization can be
realised with average CT or maximum intensity projec-
tion (MIP) CT [31]. It has been shown that calculation
algorithms overestimate the peripheral doses of moving
tumours and the underdosing effect is not noticed in the
central parts of the targets [19]. Accordingly, we can
conclude that if the studied tumours were not stationary,
the peripheral doses were likely to decrease even more
than reported in this study.
The dose calculation accuracy in the patient geometry
does not only depend on the used calculation algorithm but
also on patient anatomy, used energy, and effective field
size. This study was based on the assumption that the entire
tumour is surrounded by lung. However, tumours might be
situated close to the thoracic wall or even attached to it,
which would result in a decrease of dose build-up effects.
Conclusions
Narrow field sizes produced by HD-MLC were studied
to find the possible limitations of using small dynamic
apertures in SLRT. The surface doses of the mimicked
lung tumours decreased with decreasing the sliding win-
dow aperture. The largest deviation between measured
and calculated isodose lines was 4.2 mm, which was
recorded with a SWA of 2 mm and with the larger
tumour size studied. With a larger than 6 mm SWA the
difference in the isodose line radius between the open
and modulated field was less than 1 mm. AAA was able
to calculate the peripheral doses of the tumours accur-
ately with an average error of 1.1 mm as the measured
and calculated isodose lines of 80-95% were compared.
The PBC algorithm failed to model the peripheral dosesof the small lung tumours correctly and thus should be
used with caution in the treatments of SLRT.
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